Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

• Jacqueline A. Bayliss,

  Affiliation Department of Physiology, School of Biomedical and Psychological Sciences, Monash University, Clayton, Melbourne, Vic., 3800, Australia

  ⨯
• Moyra B. Lemus,

  Affiliation Department of Physiology, School of Biomedical and Psychological Sciences, Monash University, Clayton, Melbourne, Vic., 3800, Australia

  ⨯
• Vanessa V. Santos,

  Affiliation Department of Physiology, School of Biomedical and Psychological Sciences, Monash University, Clayton, Melbourne, Vic., 3800, Australia

  ⨯
• Minh Deo,

  Affiliation Department of Physiology, School of Biomedical and Psychological Sciences, Monash University, Clayton, Melbourne, Vic., 3800, Australia

  ⨯
• Jeffrey S. Davies,

  Affiliation Molecular Neurobiology, Institute of Life Science, Swansea University, Swansea, SA28PP, United Kingdom

  ⨯
• Bruce E. Kemp,

  Affiliation St Vincent’s Institute & Department of Medicine, The University of Melbourne, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia

  ⨯
• John D. Elsworth,

  Affiliation Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06520, United States of America

  ⨯
• Zane B. Andrews

  * E-mail: Zane.Andrews@monash.edu

  Affiliation Department of Physiology, School of Biomedical and Psychological Sciences, Monash University, Clayton, Melbourne, Vic., 3800, Australia

  http://orcid.org/0000-0002-9097-7944

  ⨯